Overcoming Challenges in Smoldering Multiple Myeloma: Improving Diagnosis and Treatment Selection

Overcoming Challenges in Smoldering Multiple Myeloma: Improving Diagnosis and Treatment Selection
Overcoming Challenges in Smoldering Multiple Myeloma: Improving Diagnosis and Treatment Selection
CME, CPE
Noopur Raje, MD
Release Date: January 18, 2021
Expiration Date: January 18, 2022

Smoldering multiple myeloma is an asymptomatic stage that occurs in between MGUS and active multiple myeloma. In this activity, Dr. Noopur Raje provides best practice regarding the diagnosis and management choice for patients with smoldering multiple myeloma. Furthermore, she describes the revised 20/2/20 risk stratification model and the implications on treatment decision making.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC and Takeda Oncology.
Begin, Earn CreditView Only, No CreditGet Certificate